SPAC9E9.04 Antibody

What is SPAC9E9.04 and why is it significant for research?

SPAC9E9.04 is a gene in Schizosaccharomyces pombe that encodes a protein involved in cell wall biosynthesis and ER function. The protein contains transmembrane domains and plays a role in protein trafficking, particularly in the endoplasmic reticulum. Its study is significant because:

• It provides insights into fundamental cellular processes conserved across eukaryotes

• Understanding its function helps elucidate protein transport mechanisms

• Mutations in related proteins are associated with altered cellular responses in higher eukaryotes

Researchers typically use antibodies against SPAC9E9.04 for localization studies, protein-protein interaction analyses, and investigating its role in protein secretion pathways .

What methods are recommended for validating a new SPAC9E9.04 antibody?

Validating a new SPAC9E9.04 antibody requires multiple complementary approaches:

Additional validation includes testing specificity against related protein family members and confirming reactivity with both native and denatured protein forms as appropriate for your application .

How should I design control experiments when using SPAC9E9.04 antibodies?

Robust experimental design requires appropriate controls:

• Genetic controls:

  • SPAC9E9.04 deletion strain (negative control)

  • Epitope-tagged SPAC9E9.04 strain (positive control)

  • Strains with altered expression levels (for antibody sensitivity testing)

• Technical controls:

  • Primary antibody omission control

  • Secondary antibody-only control

  • Pre-immune serum control (for polyclonal antibodies)

  • Isotype control (for monoclonal antibodies)

• Condition-specific controls:

  • Time-course analysis when studying dynamic processes

  • Untreated/unstressed cells as baseline

  • Additional controls during stress conditions that might affect protein levels

Critically, when performing co-localization studies, include controls with proteins known to reside in the ER versus other cellular compartments to confirm specificity of localization pattern .

What fixation and permeabilization protocols work best for immunolocalization of SPAC9E9.04?

The optimal protocol depends on preserving both epitope accessibility and subcellular structure:

For S. pombe cells, specialized spheroplasting is typically required:

• Digest cell walls using zymolyase (1 mg/ml, 30 min at 30°C)

• Fix with appropriate fixative

• Permeabilize with 0.1% Triton X-100 (5 min) or 0.1% saponin

• Block with 3% BSA in PBS for 30 minutes

For optimal results with SPAC9E9.04, which localizes primarily to the ER, using a combination of formaldehyde fixation followed by gentle permeabilization with digitonin (50 μg/ml) can preserve ER membrane structures while allowing antibody access .

How can I use SPAC9E9.04 antibodies in chromatin immunoprecipitation studies if the protein might have nuclear functions?

While SPAC9E9.04 is primarily an ER-localized protein, investigating potential transient nuclear interactions requires specialized ChIP approaches:

• Cross-linking optimization:

  • Test multiple formaldehyde concentrations (0.5-3%)

  • Consider dual cross-linking with formaldehyde plus disuccinimidyl glutarate

  • Optimize cross-linking times (5-20 minutes) to capture transient interactions

• Nuclear fractionation before ChIP:

  • Perform cellular fractionation to enrich for nuclear material

  • Verify fractionation quality by Western blot with compartment-specific markers

  • Process nuclear fraction with optimized ChIP protocol

• Sequential ChIP approach:

  • First IP with antibodies against known nuclear factors

  • Elute and perform second IP with SPAC9E9.04 antibody

  • This enriches for the subpopulation potentially involved in nuclear functions

• Controls and data interpretation:

  • Include multiple negative genomic regions in qPCR analysis

  • Use SPAC9E9.04 deletion strains as negative controls

  • Consider ChIP-seq to identify genome-wide binding patterns, with appropriate bioinformatic analysis

This approach has successfully identified non-canonical functions of other primarily ER-localized proteins in various organisms .

What are the best approaches for investigating protein-protein interactions of SPAC9E9.04?

Several complementary methods are recommended:

For membrane proteins like SPAC9E9.04, special considerations include:

• Use detergents that maintain membrane protein solubility while preserving interactions (digitonin 1%, CHAPS 1%, or DDM 0.1%)

• Include appropriate controls for membrane fraction enrichment

• Consider membrane-specific protein complementation assays like split-ubiquitin systems

• Validate key interactions with reciprocal IPs and in vitro binding assays

Recent studies using these approaches have successfully identified novel interaction partners of ER-resident proteins in S. pombe .

Why might my SPAC9E9.04 antibody work in Western blot but not in immunofluorescence?

This common issue has several potential causes and solutions:

A systematic approach to troubleshooting:

• Confirm antibody functionality by Western blot with proper controls

• Test a panel of fixation methods (formaldehyde, methanol, acetone)

• Try antigen retrieval methods (heat-induced or enzymatic)

• Increase antibody concentration and extend incubation time (overnight at 4°C)

• Use detection systems with higher sensitivity (TSA or quantum dots)

• Consider using a tagged version of the protein as a positive control

Membrane proteins like SPAC9E9.04 often require specialized conditions to preserve epitopes during fixation while still allowing antibody access .

How can I quantify SPAC9E9.04 protein levels accurately in different experimental conditions?

Accurate quantification requires rigorous methodology:

• Sample preparation standardization:

  • Harvest equal cell numbers (measured by OD600)

  • Use standardized lysis conditions (bead beating efficiency is critical for S. pombe)

  • Include protease and phosphatase inhibitors to prevent degradation

  • Normalize protein loading using BCA or Bradford assay

• Quantitative Western blot approach:

  • Use a standard curve of recombinant protein or cell lysate dilutions

  • Apply samples in technical triplicates

  • Include a normalization control (tubulin, actin, or total protein staining)

  • Use fluorescent secondary antibodies for wider linear detection range

  • Perform image acquisition within the linear range

• Data analysis rigor:

  • Subtract background for each lane individually

  • Normalize to loading control

  • Apply appropriate statistical tests for multiple comparisons

  • Present data with error bars representing biological replicates

• Alternative methods for validation:

  • Mass spectrometry-based quantification (SILAC or TMT labeling)

  • Flow cytometry (if using tagged versions)

  • Quantitative microscopy with standardized acquisition parameters

For membrane proteins like SPAC9E9.04, specific extraction methods with appropriate detergents (1% Triton X-100, 0.5% DDM, or 1% digitonin) may be necessary for complete and consistent solubilization .

How can I use SPAC9E9.04 antibodies to study its role during cellular stress responses?

Investigating SPAC9E9.04 under stress conditions requires specialized approaches:

• Stress induction protocols:

  • ER stress: DTT (2 mM, 1-4h) or tunicamycin (10 μg/ml, 2-6h)

  • Heat shock: 39°C for 1 hour

  • Oxidative stress: H₂O₂ (0.5-2 mM, 30-120 min)

  • Cell wall stress: Calcofluor white (50-200 μg/ml)

• Dynamic localization analysis:

  • Live-cell imaging with tagged protein versions

  • Fixed time-points with immunofluorescence

  • Subcellular fractionation followed by Western blot

• Protein modification analysis:

  • Phosphorylation state (Phos-tag gels or phospho-specific antibodies)

  • Ubiquitination (IP followed by ubiquitin Western blot)

  • Changes in interactome (stress vs. normal conditions)

• Functional assays:

  • ChIP analysis after stress induction

  • Ribosome profiling to assess translation effects

  • Protein half-life measurements under different conditions

A proven experimental workflow includes:

• Establish baseline expression/localization in normal conditions

• Apply stress in a time-course experiment

• Use both biochemical fractionation and imaging approaches

• Correlate protein changes with functional readouts

• Compare results in wild-type vs. mutant backgrounds

Studies have shown that some ER proteins like SPAC9E9.04 may undergo relocalization or functional changes during stress that can be captured using these approaches .

How can CRISPR-based approaches be combined with SPAC9E9.04 antibodies for advanced functional studies?

Integrating CRISPR technology with antibody-based studies enables powerful new approaches:

• Endogenous tagging strategies:

  • CRISPR knock-in of small epitope tags (FLAG, HA, Myc)

  • Advantages: Maintains native regulation, allows commercial antibody use

  • Protocol: Design guides targeting near stop codon, HDR template with tag sequence

• CUT&RUN or CUT&Tag with SPAC9E9.04 antibodies:

  • Targeted chromatin profiling using antibody-directed nuclease activity

  • Higher signal-to-noise than traditional ChIP

  • Protocol: Adapts standard protocols with cell wall digestion optimization for S. pombe

• Proximity proteomics using CRISPR-engineered fusions:

  • CRISPR knock-in of BioID, APEX, or TurboID

  • Allows mapping of protein interaction networks in specific cellular compartments

  • Analysis: MS identification of biotinylated proteins after streptavidin pulldown

• Optogenetic control combined with antibody detection:

  • CRISPR knock-in of photosensitive domains

  • Light-inducible control of SPAC9E9.04 dimerization or localization

  • Readout: Antibody-based detection of resulting protein interactions or modifications

This integration has successfully revealed dynamic responses of ER proteins to various cellular perturbations and identified conditional interactors that would be missed by traditional approaches .

What are the most effective approaches for examining post-translational modifications of SPAC9E9.04?

A comprehensive PTM analysis requires multiple complementary techniques:

Recommended workflow for comprehensive PTM mapping:

• Initial discovery phase:

  • Immunopurify SPAC9E9.04 under different conditions

  • Perform mass spectrometry with enrichment for specific PTMs

  • Generate preliminary PTM map with site identification

• Functional validation:

  • Create site-specific mutants (S→A, K→R, etc.)

  • Compare PTM status after various cellular perturbations

  • Correlate PTM changes with functional outcomes

• PTM interplay analysis:

  • Examine how one modification affects others

  • Determine temporal dynamics of modification patterns

  • Identify enzymes responsible for modifications

• Spatial mapping:

  • Determine subcellular localization of modified protein pools

  • Correlate modifications with interaction partners

  • Use modified-specific antibodies for localization studies

Recent studies have demonstrated that ER-resident proteins like SPAC9E9.04 often undergo context-dependent PTMs that regulate their function and localization .

What are the best conditions for long-term storage of SPAC9E9.04 antibodies to maintain activity?

Proper storage is critical for maintaining antibody functionality:

Additional storage recommendations:

• Physical storage conditions:

  • Use screw-cap cryovials to prevent evaporation

  • Store in the dark to prevent photobleaching (especially for conjugated antibodies)

  • Keep inventory records with freeze-thaw cycles and observed performance

• Stability testing:

  • Periodically test aliquots for activity

  • Compare new lots to reference standard

  • Document any changes in specificity or sensitivity

• Recovery after lyophilization:

  • Reconstitute slowly at 4°C

  • Centrifuge briefly to collect all material

  • Allow complete rehydration before use (≥30 minutes)

Following these guidelines will maximize antibody performance consistency across experiments .

What approaches are recommended when traditional immunoprecipitation of SPAC9E9.04 yields poor results?

When standard IP protocols fail, consider these alternative approaches:

• Membrane protein-specific solubilization:

  • Test multiple detergents:

    • Digitonin (0.5-2%): Gentle, preserves complexes

    • CHAPS (0.5-1%): Good for membrane proteins

    • DDM (0.1-0.5%): Effective for transmembrane proteins

    • SDS (0.1%) + Triton X-100 (1%): Stronger solubilization

  • Optimize detergent:protein ratios

  • Use longer solubilization times (1-2 hours) at 4°C with rotation

• Cross-linking approaches:

  • In vivo crosslinking with membrane-permeable reagents (DSP, formaldehyde)

  • Optimize crosslinker concentration and time

  • Include denaturing conditions in lysis buffer

  • Reverse crosslinks before SDS-PAGE

• Antibody coupling strategies:

  • Directly couple antibodies to beads (NHS-activated or CNBr-activated)

  • Use longer binding times (overnight at 4°C)

  • Optimize antibody:bead ratios

  • Consider biotinylated antibodies with streptavidin beads

• Alternative IP formats:

  • Miniaturized IP using magnetic beads

  • On-bead digestion for direct MS analysis

  • IP from fractionated membranes rather than whole cell lysates

  • Sequential IP to enrich for specific complexes

A systematic optimization protocol should:

• Start with comparing multiple lysis conditions

• Test antibody binding capacity and specificity

• Optimize wash conditions for signal:noise

• Validate results with alternative detection methods

For SPAC9E9.04, which contains multiple transmembrane domains, specialized membrane protein IP protocols have shown superior results to standard approaches .